- Home
- MCHX vs NRXS Comparison
MCHX vs NRXS Comparison
Compare MCHX & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCHX | NRXS |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 78.9M |
| IPO Year | 2003 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MCHX | NRXS |
|---|---|---|
| Price | $1.56 | $6.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 12.3K | ★ 213.3K |
| Earning Date | 03-25-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.13 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $90,291,000.00 | $3,569,282.00 |
| Revenue This Year | $9.12 | $142.91 |
| Revenue Next Year | N/A | $120.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 32.89 |
| 52 Week Low | $1.26 | $1.33 |
| 52 Week High | $2.30 | $7.97 |
Technical Indicators
Market Signals| Indicator | MCHX | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 52.99 | 51.68 |
| Support Level | $1.35 | $5.77 |
| Resistance Level | $1.76 | $7.97 |
| Average True Range (ATR) | 0.09 | 0.68 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 65.84 | 25.91 |
Price Performance
Historical ComparisonAbout MCHX Marchex Inc. Class B
Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).